CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,203,000 | +74.8% | 174,264 | +74.3% | 0.00% | – |
| Q3 2020 | $1,832,000 | +48.2% | 99,985 | +21.1% | 0.00% | – |
| Q2 2020 | $1,236,000 | +37.9% | 82,554 | +45.6% | 0.00% | – |
| Q1 2020 | $896,000 | +145.5% | 56,702 | +151.4% | 0.00% | – |
| Q4 2019 | $365,000 | +518.6% | 22,554 | +467.8% | 0.00% | – |
| Q3 2019 | $59,000 | +18.0% | 3,972 | +19.3% | 0.00% | – |
| Q2 2019 | $50,000 | +2.0% | 3,329 | +17.6% | 0.00% | – |
| Q1 2019 | $49,000 | -5.8% | 2,831 | -4.5% | 0.00% | – |
| Q4 2018 | $52,000 | +6.1% | 2,963 | +10.1% | 0.00% | – |
| Q3 2018 | $49,000 | +6.5% | 2,692 | +14.3% | 0.00% | – |
| Q2 2018 | $46,000 | – | 2,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|